BAC vs TYRA Stock Comparison
BAC currently leads TYRA in this stock comparison, with AIQ scores of 58 vs 49. The clearest difference is risk resilience, while TYRA has the stronger quality profile.
What is the main difference between BAC and TYRA?
BAC leads the current stock comparison as Bank of America Corporation, with the clearest separation coming from risk resilience and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
Bank of America Corporation vs Tyra Biosciences, Inc.
BAC leads
BAC leads by 9 AIQ points, primarily on Risk Resilience and Momentum, but the lead has narrowed from 22 points over 30 sessions. Wall Street currently favors TYRA on target upside.
Fragile: 3 of 5 evidence groups support BAC, its lead is narrowing, and its current signal state is conflicted.
Bank of America Corporation
Tyra Biosciences, Inc.
The Algovestiq AIQ Score currently favors BAC over TYRA, 58 versus 49 as of Nov 15, 2026. BAC's advantage is driven primarily by stronger risk resilience and momentum, while TYRA holds the stronger quality profile. BAC also shows the stronger technical structure relative to its 50-day moving average, though analyst target upside currently favors TYRA. 3 of 5 covered evidence groups favor BAC today, and the comparison is rated Fragile on stability: the leader's advantage has been narrowing. BAC lead: Weakening — the AIQ differential moved from 22 to 9 points over 30 sessions.
Compare Bank of America Corporation and Tyra Biosciences, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Total return with distributions reinvested, from daily closes.
Total return comparison
Growth of $10,000, distributions reinvested
Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.
Compare BAC and TYRA against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Risk Resilience83 vs 45BAC +38
- Quality64 vs 75TYRA +11
- Momentum37 vs 27BAC +10
3 of 5 evidence groups favor BAC. BAC’s edge is concentrated in risk resilience and momentum; TYRA keeps a meaningful quality edge.
What changed since the last close
Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.
No factor moved materially.
New signals
- OBV Bullish Divergence — bullish, volume, medium horizon (-0.4%)
Largest factor move: Momentum -3
New signals
- Low Volume Rally Warning — bearish, volume, short horizon (0.60x)
- MACD Bearish Crossover — bearish, momentum, short horizon
- MACD Histogram Expanding Bearish — bearish, momentum, short horizon
BAC's lead widened by 1 AIQ point in the latest session.
Deeper signal detail for each name lives on its own signals page — BAC and TYRA both carry a full feed there.
The central trade-off
BAC (Bank of America Corporation): the stronger current systematic profile, led by risk resilience and momentum.
TYRA (Tyra Biosciences, Inc.): the counter-case, on quality, analyst expectations — but at materially higher volatility, 51.8% against 24.8%.
The AIQ Score and Wall Street therefore point in different directions on this pair.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
BACBAC on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
TYRATYRA on combined revenue and EPS growth.
Value
EvenThe two are level on Value.
Momentum
BACBAC on the Momentum factor, by 10 points.
Lower downside
BACBAC on Risk Resilience, by 38 points.
Analyst upside
TYRATYRA on implied upside to the consensus price target.
AIQ vs Wall Street
The model and the Street disagree here: AIQ favors BAC, analyst targets favor TYRA. That disagreement is the most useful thing on this page.
| Measure | BAC | TYRA | Note |
|---|---|---|---|
| Implied upside to target | +24.1% | +118.5% | TYRA has more room |
| Target dispersion | +25.3% | +61.7% | Lower is tighter analyst agreement |
| Consensus | Buy | Buy | Context, not a primary driver |
| Analysts covering | 25 | 15 | Higher coverage generally improves confidence |
The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
3 of 5 covered evidence groups favor BAC. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | BAC | 58 vs 49 |
| Fundamentals | Even | EPS growth -23.8% vs -7.2%; TTM ROE 2.3% vs -7.4% |
| Valuation | Not covered | Not covered |
| Technicals | BAC | Price vs 50-day -5.6% vs -7.9%; vs 200-day -7% vs -31.9% |
| Risk Resilience | BAC | Risk Resilience 83 vs 45 |
| Analyst expectations | TYRA | Target upside 24.1% vs 118.5% |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of BAC and TYRA and are excluded from the count.
AIQ Decision Stability
The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.
- The AIQ gap is moderate at 9 points.
- The leader's advantage has been narrowing. (argues the conclusion is provisional)
- The leader is throwing conflicting signals. (argues the conclusion is provisional)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on BAC.
How the comparison changed
120 daily snapshots · May 27 – Nov 13BAC lead: Weakening — the AIQ differential moved from 22 to 9 points over 30 sessions.
- Today
- BAC +9
- 58 vs 49
- 7 sessions ago
- BAC +13
- 58 vs 45
- 30 sessions ago
- BAC +22
- 62 vs 40
- 90 sessions ago
- BAC +21
- 71 vs 50
The lead changed hands 3 times in this window, most recently on Jul 9 when BAC moved ahead of TYRA.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
2 bullish / 2 bearish / 1 neutral, conflicted
Only BAC
- Bollinger Band Squeeze — neutral, volatility, short horizon (4.5%)
- MACD Histogram Expanding Bullish — bullish, momentum, short horizon
- OBV Bullish Divergence — bullish, volume, medium horizon (-0.4%)
0 bullish / 5 bearish / 2 neutral
Only TYRA
- ADX Trend Weakening — neutral, trend, medium horizon
- ATR Expansion - Breakout Mode — neutral, volatility, short horizon (5.81%)
- Low Volume Rally Warning — bearish, volume, short horizon (0.60x)
- MACD Bearish Crossover — bearish, momentum, short horizon
- MACD Histogram Expanding Bearish — bearish, momentum, short horizon
Both carry 2 more signals that do not separate them: Death Cross Active, Downtrend Structure Active.
BAC leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +1.01%, AIQ 0 points).
Price is up while the AIQ Score moved down 1 points over the same session — price and model disagree (price +1.32%, AIQ -1 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1TYRA closes the Risk Resilience gap — currently 38 points behind, the largest single contributor to BAC's edge.
- 2TYRA's Death Cross Active resolves — a bearish trend rule currently active against it.
- 3BAC's conflicting signal state resolves bearish — it currently carries 2 bullish and 2 bearish rules at once.
- 4The narrowing continues — the lead has already given back 13 points over 30 sessions, and a further 9-point move would eliminate BAC's advantage entirely.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
Split| Metric | BAC | TYRA |
|---|---|---|
| Revenue growth (YoY) | -3.3% | 0% |
| EPS growth (YoY) | -23.8% | -7.2% |
| Gross margin | 60.4% | 0% |
| Operating margin | 22.4% | 0% |
| Return on equity (TTM) | 2.3% | -7.4% |
| Debt to equity | 1.28 | 0.01 |
Performance
BAC leads 4 of 6 windows| Metric | BAC | TYRA |
|---|---|---|
| 1 week (5 sessions) | 3.2% | -5.3% |
| 1 month (20 sessions) | -0.4% | 8.1% |
| 3 months (63 sessions) | -20.1% | -23.6% |
| 6 months (126 sessions) | 2.5% | -45.9% |
| Year to date | -7.2% | -23.8% |
| 1 year (252 sessions) | -5.7% | 29.4% |
Technicals
BAC has the stronger structure| Metric | BAC | TYRA |
|---|---|---|
| RSI (14) | 45.9 | 42.8 |
| ADX (14) | 27.2 | 12.1 |
| Price vs 50-day | -5.6% | -7.9% |
| Price vs 200-day | -7% | -31.9% |
| Volatility (1M, annualized) | 24.8% | 51.8% |
Risk
BAC is the more resilient| Metric | BAC | TYRA |
|---|---|---|
| Beta | 0.79 | 0.53 |
| Sharpe ratio | -0.22 | 0.65 |
| Sortino ratio | -0.29 | 1 |
| Max drawdown | -23.7% | -53.2% |
| Current drawdown | -21.3% | -49.4% |
| Annualized volatility | 22.4% | 67.9% |
| Value at risk (95%) | -2.6% | -5.3% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, BAC or TYRA?
On the Algovestiq AIQ Score, BAC is the stronger of the two as of Nov 15, 2026, scoring 58 against TYRA's 49. The edge comes from risk resilience and momentum. TYRA is not without a case — it holds the better quality profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is BAC or TYRA the better buy right now?
BAC carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Fragile — 3 of 5 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: the leader's advantage has been narrowing. Treat the lead as provisional.
Why does the AIQ Score favor BAC over TYRA?
The composite weights Quality, Value, Momentum and Risk Resilience. BAC leads Risk Resilience by 38 points; TYRA leads Quality by 11 points; BAC leads Momentum by 10 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, BAC or TYRA?
Analyst price targets imply +24.1% upside for BAC and +118.5% for TYRA, so the Street currently favors TYRA. That points the opposite way to the AIQ Score, which favors BAC. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, BAC or TYRA?
Neither name separates on the peer-relative Value factor. The two are level on Value. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, BAC or TYRA?
TYRA on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, BAC or TYRA?
BAC on the Momentum factor, by 10 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, BAC or TYRA?
BAC is the more resilient of the two, so the other name carries the higher downside risk. BAC on Risk Resilience, by 38 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is BAC more profitable than TYRA?
BAC leads on the comparable margin measures — gross margin 60.4% vs 0%; operating margin 22.4% vs 0%; ttm roe 2.3% vs -7.4%.
Is BAC's lead over TYRA getting stronger or weaker?
BAC lead: Weakening — the AIQ differential moved from 22 to 9 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has changed hands 3 times in that window, most recently on 2026-07-09, when BAC moved ahead of TYRA.
What would change the BAC vs TYRA verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: TYRA closes the Risk Resilience gap — currently 38 points behind, the largest single contributor to BAC's edge; TYRA's Death Cross Active resolves — a bearish trend rule currently active against it; BAC's conflicting signal state resolves bearish — it currently carries 2 bullish and 2 bearish rules at once; the narrowing continues — the lead has already given back 13 points over 30 sessions, and a further 9-point move would eliminate BAC's advantage entirely.
What do the current signals say about BAC and TYRA?
BAC: 2 bullish / 2 bearish / 1 neutral, conflicted. TYRA: 0 bullish / 5 bearish / 2 neutral. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on BAC is Death Cross Active (bearish, long horizon). On TYRA it is Death Cross Active (bearish, long horizon).
Compare BAC and TYRA with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.